291 related articles for article (PubMed ID: 28943977)
1. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.
Cheema E; Haseeb A; Khan TM; Sutcliffe P; Singer DR
Pharm Pract (Granada); 2017; 15(3):931. PubMed ID: 28943977
[TBL] [Abstract][Full Text] [Related]
2. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
Sweis D; Wong IC
Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
[TBL] [Abstract][Full Text] [Related]
3. A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates.
Shanableh S; Zainal H; Alomar M; Palaian S
J Pharm Policy Pract; 2023 Jul; 16(1):92. PubMed ID: 37464445
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
Hughes ML; Weiss M
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers.
Bahlol M; Bushell M; Khojah HMJ; Dewey RS
Saudi Pharm J; 2022 Jul; 30(7):1052-1059. PubMed ID: 35903525
[TBL] [Abstract][Full Text] [Related]
7. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.
Amin MN; Khan TM; Dewan SM; Islam MS; Moghal MR; Ming LC
BMJ Open; 2016 Aug; 6(8):e010912. PubMed ID: 27489151
[TBL] [Abstract][Full Text] [Related]
10. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
11. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
[TBL] [Abstract][Full Text] [Related]
12. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework.
Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
Interact J Med Res; 2022 Oct; 11(2):e40597. PubMed ID: 36222800
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
[TBL] [Abstract][Full Text] [Related]
15. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
16. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
Barnes J; Butler R
Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
[TBL] [Abstract][Full Text] [Related]
17. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
Hussain R; Hassali MA; Hashmi F; Akram T
J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction reporting by community pharmacists in the Greater Accra Region of Ghana, 2016.
Osei JY; Nortey PA; Bandoh DA; Kenu E; Addo-Lartey AA
Ghana Med J; 2021 Mar; 55(1):9-17. PubMed ID: 38322393
[TBL] [Abstract][Full Text] [Related]
19. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
[TBL] [Abstract][Full Text] [Related]
20. Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.
Khan TM
Ther Adv Drug Saf; 2013 Apr; 4(2):45-51. PubMed ID: 25083250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
